Naftifine treatment of resistant dermatophytosis.
Despite an array of topical and systemic antifungal agents, cases of resistant dermatophytosis still exist. Use of naftifine, the first commercially available allylamine derivative, proved successful in the management of four such cases.
Department of Dermatology, Baylor College of Medicine, Houston, TX 77030.
T
T
Rosen
M
M
Fischer
I
I
Orengo
F
F
Abuabara
D000279:Administration, Cutaneous; D000328:Adult; D000499:Allylamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D003881:Dermatomycoses / Q000188:drug therapy* / Q000473:pathology; D004352:Drug Resistance, Microbial; D005533:Foot Dermatoses / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D014005:Tinea / Q000188:drug therapy; D014249:Trichophyton / Q000187:drug effects
D000935:Antifungal Agents; D000499:Allylamine; C029178:naftifine